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The impact of six diabetes related complications: myo-
cardial infarction, ischemic heart disease, stroke, heart
failure and amputation on quality of life is studied based
on EQ-5D data on 3,380 patients collected in the
UKPDS Post Trial Monitoring Study over the period
1997-2007. Analysts tend to resort to cross-section data
to estimate the determinants of quality of life, as these
are easier and less expensive to collect. The use of
cross-section data may come at a cost in terms of biased
estimators due to unobserved heterogeneity that can be
addresses by the use of panel data.
The importance of non response (e.g. sample selec-
tion) is tested, and cross-sectional and longitudinal
approaches to study effects on QoL are compared. The
variation in utility across patients in our data is more
than twice that observed within a patient over-time and,
this heterogeneity is often correlated with the likelihood
of having complications, making the results of pooled
estimations biased. Cross-sectional analysis in our sam-
ple over-estimates the effects of complications on utility.
We address this problem by using fixed effects (FE).
The bulk of the variation in the unexplained utility
appears to be largely determined by time-invariant dif-
ferences across patients’ characteristics: gender, race,
socio economic status and habits. We therefore link
panel data methods with cross sectional analysis in a
two-stage analysis, using the fixed effects as the depen-
dent variable in the second stage regression to examine
the extent to which certain time-invariant patient char-
acteristics and variables recorded only at baseline in the
trial, are related to patients’ utility score. The results
highlight the importance of studying quality of life
changes over time to distinguish between time invariant
correlates of wellbeing and the effect of diabetes
complications.
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